Q2866989 (Q2866989): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item: import item from Portugal) |
(Changed label, description and/or aliases in en: Setting new description) |
||
| description / en | description / en | ||
Project in Portugal | Project Q2866989 in Portugal | ||
Revision as of 22:52, 5 July 2021
Project Q2866989 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q2866989 in Portugal |
Statements
25,000.0 Euro
0 references
76.0 percent
0 references
15 December 2017
0 references
14 December 2020
0 references
BSIM THERAPEUTICS, S.A.
0 references
O projeto TERAPI3 visa a proteção dos direitos de Propriedade Intelectual de uma nova classe de agentes terapêuticos contra doenças raras, nomeadamente doenças amiloides de transtirretina. Estes novos compostos são pequenas moléculas pertencentes à série química AT09 desenvolvida pela BSIM2. (Portuguese)
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-037867
0 references